Curcumin against chronic heart failure using a novel drug-delivery system.

Trial Profile

Curcumin against chronic heart failure using a novel drug-delivery system.

Completed
Phase of Trial: Phase II

Latest Information Update: 05 Jan 2013

At a glance

  • Drugs Curcumin (Primary)
  • Indications Left ventricular hypertrophy
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Nov 2011 Status changed from recruiting to completed, according to a Theravalues Corporation media release.
    • 10 Nov 2011 Results were reported in a Theravalues Corporation media release.
    • 07 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top